Location History:
- Kawasaki, JP (1979)
- Tokyo, JP (1985 - 1990)
Company Filing History:
4 out of 10 
2 out of 1,858 
Years Active: 1979-1990
Title: Kazuo Kigasawa: Innovator in Pharmaceutical Technology
Introduction
Kazuo Kigasawa is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical technology, holding a total of six patents. His work focuses on improving drug delivery systems, which has the potential to enhance patient care and treatment outcomes.
Latest Patents
One of Kigasawa's latest patents is an ointment base designed for external use. This innovative formulation contains a water-soluble protein and monohydric alcohol or oleaginous substances, along with a wetting agent. The ointment base significantly improves the percutaneous absorption of drugs compared to conventional ointment bases. Another notable invention is the soft patch, which is a drug preparation for external application that adheres to the skin. This preparation includes a drug, a water-soluble protein with an absorption-promoting effect, a polyhydric alcohol, a tackifier, and an oleaginous substance. The soft patch ensures improved percutaneous absorption and bioavailability of drugs, allowing for precise control of drug dosage.
Career Highlights
Throughout his career, Kigasawa has worked with prominent companies in the pharmaceutical industry. He has been associated with Grelan Pharmaceutical Co., Ltd. and Takeda Chemical Industries, Inc. His experience in these organizations has contributed to his expertise in drug formulation and delivery systems.
Collaborations
Kigasawa has collaborated with several professionals in his field, including Hideaki Ohtani and Kikuo Wakisaka. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in pharmaceutical technology.
Conclusion
Kazuo Kigasawa's contributions to pharmaceutical technology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in drug delivery systems, ultimately benefiting patients and healthcare providers alike.